New weekly shot aims to tame lupus flares and cut steroid dependence
NCT ID NCT07430306
Summary
This study is testing a weekly injection called anifrolumab, added to standard lupus medication, in people who have not yet tried strong immunosuppressant drugs. The main goal is to see if the treatment can help patients achieve a state of very low disease activity or remission. A key part of the study is to see if patients can successfully reduce or even stop their daily steroid pills while on this new therapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.